Is-Haq Malik
Endocrinology, Diabetes & Metabolism · Carbondale, ILNPI 1063998862
Payments from drug & device makers
Across 162 payments — averaging $24.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$656
- Recordati_rare_diseases_inc.$485
- Radius Health, Inc.$391
- Lilly USA, LLC$336
- Amgen$328
- Abbott$286
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,971100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 31 | $656 |
| Recordati_rare_diseases_inc. | 20 | $485 |
| Radius Health, Inc. | 16 | $391 |
| Lilly USA, LLC | 16 | $336 |
| Amgen(2 entities) | 13 | $328 |
| Abbott | 11 | $286 |
| Bayer | 3 | $260 |
| Sanofi-aventis U.S. LLC | 3 | $198 |
| Medtronic | 5 | $167 |
| Corcept Therapeutics | 8 | $153 |
| Xeris Pharmaceuticals, Inc. | 8 | $141 |
| AstraZeneca(2 entities) | 7 | $138 |
| Dexcom, Inc. | 4 | $96 |
| Tandem Diabetes Care, Inc. | 4 | $84 |
| AbbVie | 4 | $67 |
| Insulet Corporation | 2 | $39 |
| Sequel Med Tech, LLC | 2 | $39 |
| Ultragenyx Pharmaceutical Inc. | 1 | $28 |
| Boston Scientific | 1 | $23 |
| UCB, Inc. | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Mannkind Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,971 in reported general payments places this provider in the 70th percentile of 347 endocrinology, diabetes & metabolism providers in Illinois.
See all endocrinology, diabetes & metabolism providers in Illinois →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 220 | $238,052 |
| MounjaroTirzepatide | 100 | $116,883 |
| JardianceEmpagliflozin | 104 | $99,629 |
| TrulicityDulaglutide | 63 | $76,570 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $35,513 |
| FarxigaDapagliflozin Propanediol | 24 | $24,106 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 14 | $23,560 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 29 | $20,827 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 16 | $13,629 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $12,280 |
| RybelsusSemaglutide | 11 | $11,745 |
| Humalog Kwikpen U-100Insulin Lispro | 37 | $11,213 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $10,286 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 80 | $9,519 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 26 | $9,039 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $656 | $249,796231 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $336 | $199,265190 claims |
| AstraZenecaFarxiga | $138 | $24,10624 claims |
| AbbVieSynthroid | $67 | $2,57239 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 347 endocrinology, diabetes & metabolism providers in Illinois.
Other endocrinology, diabetes & metabolism in Carbondale
- Liana BillingsSkokie$3.4M
- Leon FogelfeldChicago$1.5M
- Grazia AleppoChicago$1.4M
- Wahid KassarChicago$884K
- Anthony PickLake Forest$665K
- Hiralal MaheshwariMcHenry$642K
- Wenyu HuangChicago$639K
- Babak PazookiJoliet$582K
- Silvana PannainChicago$575K
- Ammar BayrakdarEvergreen Park$517K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.